PIZZORNI, CARMEN
 Distribuzione geografica
Continente #
EU - Europa 13.651
Totale 13.651
Nazione #
IT - Italia 13.651
Totale 13.651
Città #
Genova 10.842
Rapallo 1.548
Genoa 1.200
Bordighera 61
Totale 13.651
Nome #
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. 509
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 149
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 149
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 136
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 136
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 128
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 128
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 125
Timing of transition between capillaroscopic patterns in systemic sclerosis. 124
Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. 122
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 121
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 121
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 120
Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study 119
Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. 118
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 118
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 117
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 115
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 113
Vitamin D endocrine system involvement in autoimmune rheumatic diseases 113
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. 111
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients 111
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 109
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 108
Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients 107
Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy. 107
Evidence of cerebral hypoperfusion in scleroderma patients. 106
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 106
null 105
CTLA-4 blockade in the treatment of rheumatoid arthritis: an update 105
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 105
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 105
Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. 104
Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapy. 102
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 102
Correlations between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients 102
Vitamin D, steroid hormones, and autoimmunity. 101
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts 100
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 100
Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study. 100
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 100
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 100
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon 100
Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis 99
Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al. 98
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. 98
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 97
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 96
Correlation between bone quality and microvascular damage in systemic sclerosis patients 95
Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. 95
The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. 93
Sex hormones and rheumatoid arthritis. 92
Apoptosis, sex hormones and adenosine deaminase levels in cultured monocytes (THP-1 cells) and synovial rheumatoid macrophages treated with methotrexate 92
Circadian rhythms: glucocorticoids and arthritis. 92
Prospective capillaroscopy-based study on transition from primary to secondary Raynaud's phenomenon: preliminary results. 91
Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. 90
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? 88
The apoptotic effects of testosterone on cultured synovial macrofages from rheumatoid arthrtis patients are increased by methotrexate 88
Melatonin in rheumatoid arthritis: a disease-promoting and modulating hormone? 88
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. 88
Anti-TNF and sex hormones 88
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 88
Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases. 88
Laser speckle contrast analysis: a new method to evaluate peripheral blood perfusion in systemic sclerosis patients 88
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. 87
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement]. 87
Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. 86
Intra-and inter-observer reliability of nailfold videocapillaroscopy - A possible outcome measure for systemic sclerosis-related microangiopathy. 86
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumba 86
Plantar pain is not always fasciitis 85
Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study. 85
Longterm Effects of Endothelin Receptor Antagonism on Microvascular Damage Evaluated by Nailfold Capillaroscopic Analysis in Systemic Sclerosis. 84
VITAMIN D LEVELS AND BONE LOSS IN SYSTEMIC SCLEROSIS 83
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 83
The role of androgens in rheumatic diseases. 82
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with naifold microvascular impairment 82
Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis. 82
Advanced in naifold capillaroscopic analysis in systemic sclerosis 82
Nailfold video-capillaroscopy in systemic sclerosis. 81
Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. 81
The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis 81
Androgenizing effects of cyclosporin A in rheumatoid arthritis. 81
Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. 80
Use of glucocorticoids and risk of infections. 80
The assessment of nailfold capillaries: comparison of dermoscopy and nailfold videocapillaroscopy 80
Glucocorticoid management in rheumatoid arthritis: Morning or night low dose? 80
[Nailfold capillaroscopy and blood flow laser-doppler analysis of the microvascular damage in systemic sclerosis: preliminary results]. 79
Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. 79
BONE MINERAL DENSITY AND SEASONAL VARIATIONS IN BONE TURNOVER IN SYSTEMIC SCLEROSIS PATIENTS 79
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 79
VITAMIN D STATUS AND ITS SEASONAL VARIATIONS IN PATIENTS WITH SYSTEMIC SCLEROSIS FROM NORTHWESTERN ITALY 78
Capillaroscopy 2016: new perspectives in systemic sclerosis. 78
The role of nailfold videocapillaroscopy in Raynaud's phenomenon monitoring and early diagnosis of systemic sclerosis 76
Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis. 76
Organ involvement correlates with both nailfold microangiopathy severity and fingertip blood perfusion in systemic sclerosis patients 76
Nailfold capillaroscopy-how many fingers should be examined to detect abnormality? 76
Androgens and estogens modulate the immune and inflammatory responses in rheumatoid arthritis. 75
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 75
Antiproliferative and antiinflammatory effects of methotrexate on differentiating myeloid monocytic cells and synovial macrophages from rheumatoid arthritis patients 74
Nocturnal melatonin serum level rhythm in rheumatoid arthritis 74
Totale 10.107
Categoria #
all - tutte 38.499
article - articoli 36.805
book - libri 0
conference - conferenze 1.536
curatela - curatele 0
other - altro 53
patent - brevetti 0
selected - selezionate 0
volume - volumi 105
Totale 76.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019563 0 0 0 0 0 0 0 0 0 0 294 269
2019/20204.279 199 107 152 231 365 407 558 371 488 734 504 163
2020/20211.427 76 102 376 81 93 112 51 82 137 135 100 82
2021/20222.034 54 142 160 217 55 108 172 478 118 207 95 228
2022/20231.863 200 100 23 139 335 276 18 181 302 19 245 25
2023/2024997 48 169 16 139 82 233 93 144 45 26 2 0
Totale 14.126